AbCellera Biologics Inc. - Common Shares (ABCL)
NASDAQ · Healthcare
$5.80-10.29%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $2.08B
- P/E ratio
- —
- EPS
- —
- Volume
- 6,297,636
- 52-week high
- —
- 52-week low
- —
- Open
- $6.34
- Day high
- $6.47
- Day low
- $5.78
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $75.13M | -$146.41M | -$0.49 |
| 2024 | $28.83M | -$162.86M | -$0.55 |
| 2023 | $38.03M | -$146.4M | -$0.51 |
| 2022 | $485.42M | $158.52M | $0.50 |
| 2021 | $375.2M | $153.46M | $0.48 |
About AbCellera Biologics Inc. - Common Shares
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
- CEO
- Carl Hansen
- Employees
- 596
- Country
- CA
- IPO date
- Dec 11, 2020
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is AbCellera Biologics Inc. - Common Shares's stock price today?
- ABCL is trading at $5.80 as of Jul 20, 2026.
- What is AbCellera Biologics Inc. - Common Shares's market cap?
- AbCellera Biologics Inc. - Common Shares (ABCL) has a market capitalization of $2.08B.
- Does AbCellera Biologics Inc. - Common Shares pay a dividend?
- AbCellera Biologics Inc. - Common Shares did not pay a dividend in its most recent reported fiscal year.
- What sector is AbCellera Biologics Inc. - Common Shares in?
- AbCellera Biologics Inc. - Common Shares operates in the Healthcare sector.